Re: What's the deal with Zenith?
in response to
by
posted on
Jun 22, 2023 04:08PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Who would actually be interested in purchasing a portion of Zenith owned RVX royalties/shares?
I would think it would almost have to be one of the Zenith BP partners or investors. Great way to pull them in deeper, and visualize (and maybe own) both companies someday?
This smells like an orchestration of a future BP roll up to me, in theory. And creatively using non-equity instruments for RVX financing, for keeping both entities healthy and progressing.
Pretty clever, love it ... if it is anything close to what I am smelling.